212 Co‐delivery of Vitamin D3 and Antigens by Nanoparticles Enhances Immune Tolerance through Induction of Tolerogenic Dendritic Cells in vivo

Author:

Gao Xue12,Cong Xiuxiu12,Li He12,Mao Kuirong123,Wang Haorui123,Lin Guojiao12,Wang Jialiang12,Liu Feiqi12,Zhu Ge12,Tan Huizhu12,Zhang Yuning12,Sun Liguang123,Yang Yong‐Guang123,Sun Tianmeng1234ORCID

Affiliation:

1. Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education Institute of Immunology, The First Hospital, Jilin University Changchun Jilin 130029 P. R. China

2. National‐local Joint Engineering Laboratory of Animal Models for Human Diseases Changchun Jilin 130029 P. R. China

3. International Center of Future Science Jilin University Changchun Jilin 130029 P. R. China

4. State Key Laboratory of Supramolecular Structure and Materials Jilin University Changchun Jilin 130015 P. R. China

Abstract

AbstractTolerogenic dendritic cells (tDCs) induces regulatory T cell (Treg) differentiation and promotes immune tolerance. However, the effective generation of tDCs in vivo to treat autoimmune diseases remains a significant challenge. In this study, the potential of 1α, 25‐Dihydroxyvitamin D3 (VD3) is explored, which has been shown to promote tDCs differentiation in vitro, to induce tDCs in a mouse model of experimental autoimmune encephalomyelitis (EAE). To overcome the poor solubility of VD3 and induce autoantigen‐specific Tregs, a PLGA‐PEG‐based nano‐drug delivery system is prepared to co‐deliver VD3 and myelin‐oligodendrocyte glycoprotein (MOG) peptides. It is found that intradermal (i.d.) injection of NP/VD3/MOG significantly enhanced the level of antigen‐specific Tregs in vivo. Furthermore, NP/VD3/MOG remarkedly delayed the onset, reduced the severity, and promoted the recovery of EAE mice. This study provides an effective strategy for the treatment of autoimmune diseases.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3